Show Summary Details
Page of

Psychiatrists and the Pharmaceutical Industry: On the Ethics of a Complex Relationship 

Psychiatrists and the Pharmaceutical Industry: On the Ethics of a Complex Relationship
Chapter:
Psychiatrists and the Pharmaceutical Industry: On the Ethics of a Complex Relationship
Author(s):

Philip B. Mitchell

DOI:
10.1093/med/9780199213962.003.0022
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 October 2019

Philip Mitchell examines the challenge to the reputation of psychiatry arising from its aberrant relationship with pharmaceutical companies. There has been public, media, and institutional concern about this relationship. Proceeding from the assumption that it is not the relationship per se but how it operates, the chapter considers how it is dysfunctional and may be reformed. The chapter reviews general literature on the relationship of doctors to industry, specific points of contact, why psychiatrists are in the dubious lead, and how various bodies are responding, through professional organizations, medical schools, medical journals, and pharmaceutical industry organizations. The challenge of integrity and transparency is one that affects credibility and confidence in the profession.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.